Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP913648.RA6TOl69fm9odiIIN0JNcFRc3V3mO-IxmSaKsp82an3FU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP913648.RA6TOl69fm9odiIIN0JNcFRc3V3mO-IxmSaKsp82an3FU130_assertion type Assertion NP913648.RA6TOl69fm9odiIIN0JNcFRc3V3mO-IxmSaKsp82an3FU130_head.
- NP913648.RA6TOl69fm9odiIIN0JNcFRc3V3mO-IxmSaKsp82an3FU130_assertion wasGeneratedBy ECO_0000203 NP913648.RA6TOl69fm9odiIIN0JNcFRc3V3mO-IxmSaKsp82an3FU130_provenance.
- NP913648.RA6TOl69fm9odiIIN0JNcFRc3V3mO-IxmSaKsp82an3FU130_assertion wasDerivedFrom befree-20140225 NP913648.RA6TOl69fm9odiIIN0JNcFRc3V3mO-IxmSaKsp82an3FU130_provenance.
- NP913648.RA6TOl69fm9odiIIN0JNcFRc3V3mO-IxmSaKsp82an3FU130_assertion SIO_000772 22898604 NP913648.RA6TOl69fm9odiIIN0JNcFRc3V3mO-IxmSaKsp82an3FU130_provenance.
- NP913648.RA6TOl69fm9odiIIN0JNcFRc3V3mO-IxmSaKsp82an3FU130_assertion evidence source_evidence_literature NP913648.RA6TOl69fm9odiIIN0JNcFRc3V3mO-IxmSaKsp82an3FU130_provenance.
- NP913648.RA6TOl69fm9odiIIN0JNcFRc3V3mO-IxmSaKsp82an3FU130_assertion description "[Our studies demonstrate that inhibitors of autophagy or cathepsin B activity and/or molecular targeting of p62/SQSTM1, Atg7, or cathepsin B result in partial reversal of the suppressive effects of AS(2)O(3) on BCR-ABL expressing leukemic progenitors, including primitive leukemic precursors from chronic myelogenous leukemia (CML) patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP913648.RA6TOl69fm9odiIIN0JNcFRc3V3mO-IxmSaKsp82an3FU130_provenance.